A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy

医学 肝细胞癌 无线电技术 内科学 化疗 肿瘤科 放射科
作者
Xuelei He,Kai Li,Ran Wei,Mengxuan Zuo,Wang Yao,Zechen Zheng,Xiaowei He,Yan Fu,Chengzhi Li,Chao An,Wendao Liu
出处
期刊:Radiologia Medica [Springer Science+Business Media]
卷期号:128 (12): 1508-1520 被引量:17
标识
DOI:10.1007/s11547-023-01719-1
摘要

Abstract Background The macrotrabecular-massive (MTM) is a special subtype of hepatocellular carcinoma (HCC), which has commonly a dismal prognosis. This study aimed to develop a multitask deep learning radiomics (MDLR) model for predicting MTM and HCC patients’ prognosis after hepatic arterial infusion chemotherapy (HAIC). Methods From June 2018 to March 2020, 158 eligible patients with HCC who underwent surgery were retrospectively enrolled in MTM related cohorts, and 752 HCC patients who underwent HAIC were included in HAIC related cohorts during the same period. DLR features were extracted from dual-phase (arterial phase and venous phase) contrast-enhanced computed tomography (CECT) of the entire liver region. Then, an MDLR model was used for the simultaneous prediction of the MTM subtype and patient prognosis after HAIC. The MDLR model for prognostic risk stratification incorporated DLR signatures, clinical variables and MTM subtype. Findings The predictive performance of the DLR model for the MTM subtype was 0.968 in the training cohort [TC], 0.912 in the internal test cohort [ITC] and 0.773 in the external test cohort [ETC], respectively. Multivariable analysis identified portal vein tumor thrombus (PVTT) ( p = 0.012), HAIC response ( p < 0.001), HAIC sessions ( p < 0.001) and MTM subtype ( p < 0.001) as indicators of poor prognosis. After incorporating DLR signatures, the MDLR model yielded the best performance among all models (AUC, 0.855 in the TC, 0.805 in the ITC and 0.792 in the ETC). With these variables, the MDLR model provided two risk strata for overall survival (OS) in the TC: low risk (5-year OS, 44.9%) and high risk (5-year OS, 4.9%). Interpretation A tool based on MDLR was developed to consider that the MTM is an important prognosis factor for HCC patients. MDLR showed outstanding performance for the prognostic risk stratification of HCC patients who underwent HAIC and may help physicians with therapeutic decision making and surveillance strategy selection in clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
TGU2331161488发布了新的文献求助10
刚刚
刚刚
明理的霸完成签到,获得积分10
1秒前
2秒前
2秒前
yue957完成签到,获得积分10
2秒前
今后应助csu_zs采纳,获得10
2秒前
大个应助帅气的可乐采纳,获得10
4秒前
大宝慧发布了新的文献求助10
4秒前
4秒前
晴天完成签到,获得积分10
5秒前
FireNow完成签到,获得积分10
5秒前
6秒前
温热如河应助zhangyu采纳,获得10
6秒前
xy完成签到,获得积分10
6秒前
Lucas应助付品聪采纳,获得10
6秒前
yue957发布了新的文献求助10
6秒前
希望天下0贩的0应助77采纳,获得10
7秒前
zzr真真97发布了新的文献求助10
7秒前
7秒前
狄谷南完成签到,获得积分10
7秒前
脑洞疼应助潘2333采纳,获得10
7秒前
SciGPT应助Chong采纳,获得10
8秒前
8秒前
9秒前
正直的沛凝完成签到,获得积分10
9秒前
科研通AI2S应助Wu采纳,获得10
9秒前
CodeCraft应助lmg采纳,获得10
10秒前
基尔霍夫完成签到,获得积分10
10秒前
10秒前
CR7应助Yue采纳,获得20
10秒前
haha发布了新的文献求助10
11秒前
我是老大应助开放雪曼采纳,获得10
11秒前
彩色的向珊完成签到,获得积分20
11秒前
kx发布了新的文献求助10
12秒前
Avert.发布了新的文献求助30
12秒前
12秒前
hjhj完成签到,获得积分10
12秒前
风趣的老太应助樱悼柳雪采纳,获得10
13秒前
13秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974712
求助须知:如何正确求助?哪些是违规求助? 3519159
关于积分的说明 11197254
捐赠科研通 3255257
什么是DOI,文献DOI怎么找? 1797724
邀请新用户注册赠送积分活动 877130
科研通“疑难数据库(出版商)”最低求助积分说明 806132